Edwards Lifesciences Net Change in Property, Plant, and Equipment 2010-2025 | EW
Edwards Lifesciences annual/quarterly net change in property, plant, and equipment history and growth rate from 2010 to 2025. Net change in property, plant, and equipment can be defined as the overall change in capital expenditures and sales of plant, property and equipment. This field is used if a company does not report separately sales and purchases of plant, property and equipment or is calculated as the sum of purchases and sales of PP&E
- Edwards Lifesciences net change in property, plant, and equipment for the quarter ending March 31, 2025 was $-56M, a 14.24% decline year-over-year.
- Edwards Lifesciences net change in property, plant, and equipment for the twelve months ending March 31, 2025 was $-0.662B, a 11.7% increase year-over-year.
- Edwards Lifesciences annual net change in property, plant, and equipment for 2024 was $-0.252B, a 0.24% decline from 2023.
- Edwards Lifesciences annual net change in property, plant, and equipment for 2023 was $-0.253B, a 3.43% increase from 2022.
- Edwards Lifesciences annual net change in property, plant, and equipment for 2022 was $-0.245B, a 24.92% decline from 2021.
| Edwards Lifesciences Annual Net Change in Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2024 | $-252 |
| 2023 | $-253 |
| 2022 | $-245 |
| 2021 | $-326 |
| 2020 | $-407 |
| 2019 | $-254 |
| 2018 | $-239 |
| 2017 | $-168 |
| 2016 | $-176 |
| 2015 | $-103 |
| 2014 | $-80 |
| 2013 | $-107 |
| 2012 | $-106 |
| 2011 | $-73 |
| 2010 | $-55 |
| 2009 | $34 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $43.397B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $182.611B | 79.98 |
| Thermo Fisher Scientific (TMO) | United States | $148.189B | 17.92 |
| Alcon (ALC) | Switzerland | $41.812B | 28.26 |
| IDEXX Laboratories (IDXX) | United States | $41.807B | 48.04 |
| DexCom (DXCM) | United States | $31.765B | 49.10 |
| IQVIA Holdings (IQV) | United States | $26.748B | 14.98 |
| Mettler-Toledo (MTD) | United States | $23.806B | 28.31 |
| STERIS (STE) | Ireland | $23.238B | 25.59 |
| Waters (WAT) | United States | $20.195B | 28.49 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.992B | 0.00 |
| Hologic (HOLX) | United States | $14.255B | 15.49 |
| Sysmex ADR (SSMXY) | Japan | $10.670B | 30.27 |
| Penumbra (PEN) | United States | $9.953B | 78.12 |
| Masimo (MASI) | United States | $8.825B | 32.55 |
| Globus Medical (GMED) | United States | $7.767B | 18.51 |
| Glaukos (GKOS) | United States | $5.848B | 0.00 |
| Teleflex (TFX) | United States | $5.202B | 8.59 |
| TransMedics (TMDX) | United States | $4.194B | 91.18 |
| Integer Holdings (ITGR) | United States | $4.151B | 21.75 |
| PROCEPT BioRobotics (PRCT) | United States | $3.301B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.463B | 14.67 |
| Veracyte (VCYT) | United States | $2.100B | 29.47 |
| Nihon Kohden (NHNKY) | Japan | $1.988B | 22.80 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 16.93 |
| Alphatec Holdings (ATEC) | United States | $1.592B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.359B | 0.00 |
| Artivion (AORT) | United States | $1.268B | 118.80 |
| OPKO Health (OPK) | United States | $1.023B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.012B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.926B | 4.92 |
| Beta Bionics (BBNX) | United States | $0.771B | 0.00 |
| IRadimed (IRMD) | United States | $0.743B | 37.71 |
| SiBone (SIBN) | United States | $0.711B | 0.00 |
| RxSight (RXST) | United States | $0.564B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.559B | 8.69 |
| Mesa Laboratories (MLAB) | United States | $0.507B | 11.89 |
| Delcath Systems (DCTH) | United States | $0.493B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.489B | 0.00 |
| AxoGen (AXGN) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.406B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.393B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.356B | 9.48 |
| NeuroPace (NPCE) | United States | $0.348B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.343B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.315B | 0.00 |
| 908 Devices (MASS) | United States | $0.286B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.03 |
| Neuronetics (STIM) | United States | $0.222B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.221B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.205B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| CVRx (CVRX) | United States | $0.152B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Accuray (ARAY) | United States | $0.127B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.40 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.39 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |